Novogen Limited Stock Australian S.E.
Equities
AU000000NRT0
Biotechnology & Medical Research
Sales 2022 | 10K 6.67K | Sales 2023 | 555 370.07 | Capitalization | 39.72M 26.48M |
---|---|---|---|---|---|
Net income 2022 | -24M -16M | Net income 2023 | -20M -13.34M | EV / Sales 2022 | 7,714 x |
Net cash position 2022 | 7.36M 4.91M | Net cash position 2023 | 3.44M 2.3M | EV / Sales 2023 | 65,355 x |
P/E ratio 2022 |
-3.27
x | P/E ratio 2023 |
-1.55
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.6% |
Latest transcript on Novogen Limited
1st Jan change | Capi. | |
---|---|---|
+44.48% | 54.04B | |
+43.57% | 41.96B | |
-0.86% | 41.92B | |
-7.59% | 28.35B | |
+12.30% | 26.35B | |
-21.83% | 19B | |
+7.15% | 13B | |
+29.40% | 12.28B | |
+25.15% | 12.19B |